Make Money And Do Good: The Case For Investing In Neurology Start-Ups

It remains extremely challenging to raise money for start-ups in the neuroscience space that still have little data but the commercial possibilities for those investors prepared to take a punt are huge.

LSE panel
The neurology panel at the Future of Healthcare investment forum • Source: Weatherall Photography

There has been an uptick in investor interest in non-oncology therapy areas in the past couple of years, with neuroscience again becoming a hot area, but biotechs in the space are finding that access to funding is still very tricky.

That was one of the key messages that came out of a panel on neurology moderated by Scrip at the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapeutic Category